Concentrated Australian Share Fund

Fund overview

The Investors Mutual Concentrated Australian Share Fund provides exposure to an actively managed, concentrated portfolio of quality shares listed on the ASX. The Fund will aim to provide attractive investment opportunities for investors seeking medium to long term capital growth with income. The Fund applies IML’s conservative value based investment philosophy with a long term focus and aims to deliver consistent returns to clients.


Investors Mutual Concentrated Australian Share Fund

Hugh Giddy provides an introduction to the Investors Mutual Concentrated Australian Share Fund, the companies it invests in, the outcomes of the fund & how it differs from a stereotypical concentrated fund.

Fund Facts

  • Portfolio Managers:
    Hugh Giddy
  • Benchmark:
    S&P/ASX 300 Accumulation Index
  • Inception:
    1 Sept 2010
  • ARSN:
    145 759 879
  • APIR:
  • Distribution Frequency:
    Generally semi-annually
  • Performance fee:
    10.25% (10% inclusive of the net effect of GST) of investment returns made in excess of 2% above the Benchmark.
  • Management fee:
    0.993% p.a. of the net assets of the fund (includes GST)

Investment Objective

The Fund aims to provide a rate of return (after fees and expenses and before taxes) which exceeds the return of the S&P/ASX 300 Accumulation Index on a rolling five year basis.  

Investment Strategy

The Fund will invest in a concentrated portfolio of quality ASX listed Australian and New Zealand shares, where these shares are identified by our investment team as being undervalued.

Net Performance

Unit Prices

Distribution Information

Period Ending Distribution
December 2021 2.0 cpu
June 2021 1.5 cpu
December 2020 1.0 cpu
June 2020 2.4 cpu
December 2019 2.25 cpu
June 2019 3.8 cpu
December 2018 2.25 cpu
June 2018 2.9 cpu
December 2017 2.0 cpu
June 2017 2.7 cpu
December 2016 1.5 cpu
June 2016 2.4 cpu
December 2015 1.5 cpu
June 2015 2.2 cpu
December 2014 2.5 cpu
June 2014 12.0 cpu

Past performance is not indicative of future performance as a result past distributions are not indicative of future distributions.For more information please refer to our Distributions page

Ratings and Awards

Researcher Rating
Morningstar Gold
Lonsec Contact IML for the most recent rating
Zenith Recommended


mstar gold   Zenith Recommended

For the most recent research house ratings report please contact your state manager.

© 2022 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice or ‘class service’ have been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. Refer to our Financial Services Guide (FSG) for more information at // You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser.
The Zenith Investment Partners (“Zenith”) Australian Financial Services License No. 226872 rating (assigned 24 June 21) referred to in this document is limited to “General Advice” (as defined by the Corporations Act 2001) for Wholesale clients only. This advice has been prepared without taking into account the objectives, financial situation or needs of any individual. It is not a specific recommendation to purchase, sell or hold the relevant product(s). Investors should seek independent financial advice before making an investment decision and should consider the appropriateness of this advice in light of their own objectives, financial situation and needs. Investors should obtain a copy of, and consider the PDS or offer document before making any decision and refer to the full Zenith Product Assessment available on the Zenith website. Zenith usually charges the product issuer, fund manager or a related party to conduct Product Assessments. Full details regarding Zenith’s methodology, ratings definitions and regulatory compliance are available on our Product Assessment’s and at

View more